Australia TGA Medical Device Registration

Regulatory Oversight of the Therapeutic Goods Administration

The Australian medical device market is regulated by the Therapeutic Goods Administration (TGA), a division of the Department of Health and Aged Care. The TGA is responsible for administering the Therapeutic Goods Act 1989 and the Therapeutic Goods (Medical Devices) Regulations 2002. Its primary mandate is to ensure that therapeutic goods available in Australia—including medical devices and In Vitro Diagnostics (IVDs)—meet high standards for safety, quality, and performance.

All medical devices must be entered into the Australian Register of Therapeutic Goods (ARTG) before they can be legally supplied, imported, or exported from Australia. The TGA employs a risk-based approach to regulation, where the level of pre-market assessment and post-market monitoring is proportional to the potential risk the device poses to the public.

Risk Classification and Technical Evidence

Medical devices in Australia are categorized into classes based on their intended purpose and the degree of risk associated with their use.

Classification Categories under TGA Regulations

The classification system for medical devices ranges from Class I (lowest risk) to Class III (highest risk). Class I devices include products such as bandages and non-sterile tongue depressors. Class IIa and IIb represent moderate to high-risk devices, such as hearing aids and surgical lasers. Class III is reserved for the highest-risk devices, including heart valves and implanted pacemakers. For IVDs, the classification follows a similar logic from Class 1 to Class 4. Accurate classification is essential as it dictates the specific conformity assessment evidence required for ARTG entry.

Quality Management and MDSAP Participation

Manufacturers must demonstrate that their products are manufactured under a robust quality management system (QMS). The TGA recognizes ISO 13485 certification as a primary means of demonstrating compliance. Furthermore, Australia is a founding member of the Medical Device Single Audit Program (MDSAP). A valid MDSAP audit report can significantly streamline the registration process by satisfying the QMS requirements of the TGA alongside those of other participating international regulators.

Market Access and Licensing Procedures

The process for achieving market access in Australia involves specific legal and administrative steps that must be managed by an Australian-based entity.

The Role of the Australian Sponsor

For manufacturers located outside of Australia, the appointment of an Australian Sponsor is a mandatory legal requirement. The Sponsor must be a resident of Australia or a body corporate incorporated in Australia. The Sponsor acts as the legal representative for the manufacturer and is responsible for submitting the application for ARTG entry. Beyond registration, the Sponsor serves as the primary liaison with the TGA, handles the payment of annual fees, and manages post-market obligations such as adverse event reporting.

ARTG Entry and Application Review

The pathway to ARTG entry involves the submission of a manufacturer's evidence (typically a QMS certificate) followed by a device application. For certain high-risk devices or those without recognized overseas certification, the TGA may conduct a mandatory audit or a detailed technical file review. Once the TGA is satisfied that the device meets the Essential Principles for safety and performance, the device is included in the ARTG, and a certificate is issued. ARTG inclusions do not have a formal expiration date, provided that annual fees are paid and the manufacturer maintains valid conformity assessment evidence.

Post-market Surveillance and Vigilance

Inclusion in the ARTG carries ongoing responsibilities for both the manufacturer and the Australian Sponsor. The TGA maintains a rigorous post-market surveillance program to ensure the continued safety of devices in clinical use.

Sponsors are legally required to report any adverse events or "near misses" to the TGA within specific timeframes—ranging from 48 hours for serious public health threats to 30 days for other incidents. Additionally, if a manufacturer identifies a need for a recall or a field safety corrective action, the Sponsor must coordinate with the TGA to ensure the effective removal or remediation of the affected products within the Australian supply chain.

Proregulations' Australia TGA Registration Services

Our standardized service process facilitates the efficient navigation of the Australian regulatory landscape to ensure your products meet all requirements of the TGA.

• Australian Sponsor representation
• TGA product classification and regulatory strategy
• Submission of manufacturer's evidence and ARTG applications
• MDSAP report utilization and QMS support
• Technical documentation and Essential Principles review
• Post-market vigilance and adverse event reporting assistance

If you are interested in our Australia TGA registration services and wish to secure your market position in Australia, please feel free to contact us.